It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.
Accurate, regulatory-compliant translations for cutting-edge genetic research, clinical studies, and therapeutic innovations.
Genomics and gene therapy are revolutionizing modern medicine—driving breakthroughs in gene editing, personalized therapeutics, and rare disease treatment. As research accelerates toward clinical application and global commercialization, precise scientific communication across languages becomes essential. Sesen supports this transformation by delivering expert genomics translation services purpose-built for the complexities of life sciences.
In a field where precision is critical, even minor linguistic errors can result in regulatory delays, compromised data integrity, or patient risk. Our gene therapy and genomics translation services ensure terminological consistency, regulatory alignment, and linguistic accuracy to help biotech companies, research institutions, and CROs succeed in multinational trials and global product launches.
Genomics and gene therapy involve highly specialized language drawn from disciplines such as molecular biology, bioinformatics, and genetic engineering. Terminology related to CRISPR, recombinant vectors, gene silencing, and nucleotide sequencing is complex and rapidly evolving—requiring translators with deep domain knowledge to maintain scientific integrity across languages.
Sesen provides expert language support tailored to these scientific and technical demands. Our linguists possess subject-matter expertise and the training necessary to accurately convey complex genomic concepts while preserving terminological consistency and scientific nuance.
Equally critical is adherence to a rigorous regulatory framework. Whether preparing clinical trial documentation, regulatory submissions, or patient-facing materials, translations must comply with global standards, including EMA, FDA, and ICH guidelines. Errors or inconsistencies can lead to costly delays, rejections, or legal exposure.
Finally, the inherently global nature of gene-based research demands seamless communication across borders. From multinational clinical trials and global investigator networks to the commercialization of genetic therapies in diverse markets, Sesen ensures precise, compliant translations that support international collaboration and successful market entry.
Sesen delivers high-precision translation services backed by deep subject matter expertise. Our linguists have academic and professional backgrounds in molecular biology, biochemistry, and biotechnology, enabling them to accurately translate complex content involving gene editing technologies, viral vectors, and genomic sequencing.
We work exclusively with native-speaking experts who are well-versed in region-specific terminology and regulatory language. This ensures that all translations—whether for clinical documentation, regulatory filings, or patient-facing materials—are both linguistically accurate and globally compliant.
Sesen has supported a range of projects across the genomics and gene therapy landscape, including translations for clinical trial protocols, informed consent forms, and global regulatory submissions. Our experience enables us to navigate the scientific, linguistic, and compliance requirements unique to this rapidly advancing field.
Sesen provides specialized translation services for a wide range of document types supporting genomics and gene therapy programs, from early research through clinical development and commercialization.
Accurate translations of clinical protocols and IBs ensure consistency in study execution and regulatory compliance across global trial sites. Sesen handles complex scientific language and medical terminology with precision, supporting clear communication with investigators and ethics committees.
We translate ICFs to meet local linguistic and cultural norms while maintaining legal and ethical compliance. Our linguists prioritize clarity and readability, ensuring that patients fully understand study procedures, risks, and rights in their native language.
Sesen provides high-accuracy translations for regulatory documents submitted to agencies like the FDA, EMA, and PMDA. Our workflows support rapid turnaround and strict adherence to global regulatory standards, minimizing risks of delays or rejection.
From preclinical findings to Phase III trial results, we translate peer-reviewed articles, white papers, and final study reports for global dissemination. Scientific accuracy and terminological consistency are maintained across all languages.
Our translations of recruitment flyers, websites, and outreach content are tailored to local cultural contexts while staying aligned with study messaging and compliance requirements. We help you engage diverse patient populations across multiple regions.
Sesen translates pre- and post-test genetic counseling materials with attention to both scientific detail and patient comprehension. Our linguists handle sensitive content with accuracy and empathy to support informed decision-making.
We translate SOPs, training manuals, and procedural documentation for gene-editing technologies such as CRISPR. Terminology is aligned with industry standards to ensure safety, reproducibility, and regulatory readiness.
Sesen localizes user interfaces, dashboards, and workflow screens for genomic data platforms and bioinformatics tools. Our linguists collaborate with engineers to preserve functionality, context, and scientific accuracy.
We translate brochures, websites, press releases, and campaign materials used to promote gene-based therapeutics in global markets. Content is adapted to resonate with regional audiences while maintaining scientific integrity and brand voice.
Sesen’s translation workflows are built to meet the stringent quality and compliance requirements of the life sciences sector. We are certified to ISO 17100 for translation services, ISO 13485 for medical device quality management, and ISO 9001:2015 for overall quality assurance—ensuring a structured, auditable approach to translation quality.
All genomic and gene therapy content is reviewed by qualified subject matter experts and senior QA linguists to verify scientific accuracy, terminological consistency, and regulatory alignment. Where required, we offer in-country review and back translation to meet the expectations of ethics committees, institutional review boards (IRBs), and regulatory bodies.
Our processes are fully aligned with the requirements of global health authorities, including the FDA, EMA, PMDA, and Health Canada, supporting successful submissions and cross-border trial readiness. Sesen helps ensure that your content not only reads correctly—it meets regulatory expectations in every language and jurisdiction.
Sesen combines advanced translation technology with human expertise to deliver fast, consistent, and scientifically accurate results. We leverage industry-leading CAT tools and translation memory systems to ensure terminology consistency across complex genomic and therapeutic content, while reducing turnaround time and cost.
For high-volume projects, we offer Machine Translation Post-Editing (MTPE)—a hybrid solution where pre-translated content is reviewed and refined by expert linguists with subject-matter training. This approach supports scalability without compromising the quality required for regulatory or clinical documentation.
To protect sensitive genetic, clinical, and patient data, Sesen implements robust data security protocols, including end-to-end encryption, access controls, and infrastructure hosted on Amazon Web Services (AWS). Our platform architecture is designed to meet the privacy and confidentiality requirements of life sciences clients operating in regulated environments.
Sesen provides specialized translation services in over 100 languages to support the global rollout of genomics and gene therapy programs. We cover all major languages commonly required in the industry, including Chinese, Japanese, Korean, German, French, Spanish, Portuguese, and others critical to international clinical development and regulatory engagement.
Our linguists bring regional expertise across key markets, including Europe, APAC, LATAM, and MENA, ensuring that all content—from clinical trial documentation to regulatory filings and patient communications—is linguistically accurate, culturally appropriate, and compliant with local health authority standards.
By combining scientific precision with regional fluency, Sesen enables biotech companies, CROs, and research sponsors to conduct multilingual trials efficiently and communicate effectively with stakeholders worldwide.
Sesen provides specialized localization services for software applications and digital tools used in genomics and gene therapy research. We translate and adapt user interfaces, dashboards, and user guides for genetic analysis platforms and next-generation sequencing (NGS) tools—ensuring that scientists and clinicians can interact with technology in their native language without compromising functionality or precision.
Our team also supports the localization of electronic health record (EHR) integrations, AI-powered data analytics tools, and bioinformatics workflows, maintaining consistency across clinical, research, and regulatory environments.
By combining linguistic accuracy with domain-specific knowledge, Sesen ensures that localized software retains both scientific integrity and user usability, enabling effective global deployment of digital solutions in precision medicine and genetic research. To learn more about Sesen’s comprehensive software localization solutions, please click here.
At Sesen, every genomics and gene therapy translation project is led by a dedicated project manager with specialized experience in life sciences. Our project managers understand the scientific, regulatory, and logistical requirements unique to gene-based therapies, ensuring a seamless translation workflow from kickoff to delivery.
We provide proactive timeline management to meet the demands of fast-moving clinical trials and regulatory submissions. Whether working toward IND filing deadlines, ethics committee approvals, or multi-site trial rollouts, our team keeps your project on track and aligned with critical milestones.
To maintain transparency and alignment, Sesen offers weekly or monthly review meetings tailored to your preferences. These sessions provide progress updates, address open items, and help anticipate upcoming needs—ensuring full visibility and ongoing quality control across global programs.
Sesen is the trusted language partner for biotechnology companies advancing genomics and gene therapy breakthroughs. Our exclusive focus on life sciences ensures that every project is grounded in deep domain expertise, regulatory understanding, and scientific accuracy.
We offer a hybrid translation approach that blends cutting-edge language technology with expert human review—delivering scalable, high-quality results without compromising precision. Our dedicated project teams operate with speed, transparency, and responsiveness, providing real-time communication and full visibility throughout the project lifecycle.
What sets Sesen apart is our commitment to scientific rigor at every step—from terminology management and quality control to region-specific regulatory alignment. Whether you're translating clinical documentation, software interfaces, or regulatory submissions, Sesen delivers the linguistic and technical accuracy required for global success.
Partner with Sesen to ensure your genomics and gene therapy content is accurately translated, globally compliant, and ready for international success. Whether you’re preparing for clinical trials, regulatory submissions, or market launch, our specialized team is here to support every step.